These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. An aluminum-based rat model for Alzheimer's disease exhibits oxidative damage, inhibition of PP2A activity, hyperphosphorylated tau, and granulovacuolar degeneration. Walton JR J Inorg Biochem; 2007 Sep; 101(9):1275-84. PubMed ID: 17662457 [TBL] [Abstract][Full Text] [Related]
9. Neuronal COX-2 expression and phosphorylation of pRb precede p38 MAPK activation and neurofibrillary changes in AD temporal cortex. Hoozemans JJ; Veerhuis R; Rozemuller AJ; Arendt T; Eikelenboom P Neurobiol Dis; 2004 Apr; 15(3):492-9. PubMed ID: 15056456 [TBL] [Abstract][Full Text] [Related]
10. Neuronal activity and early neurofibrillary tangles in Alzheimer's disease. Hatanpää K; Brady DR; Stoll J; Rapoport SI; Chandrasekaran K Ann Neurol; 1996 Sep; 40(3):411-20. PubMed ID: 8797530 [TBL] [Abstract][Full Text] [Related]
11. Neurological cholinesterases in the normal brain and in Alzheimer's disease: relationship to plaques, tangles, and patterns of selective vulnerability. Wright CI; Geula C; Mesulam MM Ann Neurol; 1993 Sep; 34(3):373-84. PubMed ID: 8363355 [TBL] [Abstract][Full Text] [Related]
12. Phosphorylated serine 199 of microtubule-associated protein tau is a neuronal epitope abundantly expressed in youth and an early marker of tau pathology. Maurage CA; Sergeant N; Ruchoux MM; Hauw JJ; Delacourte A Acta Neuropathol; 2003 Feb; 105(2):89-97. PubMed ID: 12536218 [TBL] [Abstract][Full Text] [Related]
13. JNK plays a key role in tau hyperphosphorylation in Alzheimer's disease models. Ploia C; Antoniou X; Sclip A; Grande V; Cardinetti D; Colombo A; Canu N; Benussi L; Ghidoni R; Forloni G; Borsello T J Alzheimers Dis; 2011; 26(2):315-29. PubMed ID: 21628793 [TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical study of tau accumulation in early stages of Alzheimer-type neurofibrillary lesions. Togo T; Akiyama H; Iseki E; Uchikado H; Kondo H; Ikeda K; Tsuchiya K; de Silva R; Lees A; Kosaka K Acta Neuropathol; 2004 Jun; 107(6):504-8. PubMed ID: 15024583 [TBL] [Abstract][Full Text] [Related]
15. Expression profile of transcripts in Alzheimer's disease tangle-bearing CA1 neurons. Ginsberg SD; Hemby SE; Lee VM; Eberwine JH; Trojanowski JQ Ann Neurol; 2000 Jul; 48(1):77-87. PubMed ID: 10894219 [TBL] [Abstract][Full Text] [Related]
16. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons. Padmanabhan J; Levy M; Dickson DW; Potter H Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932 [TBL] [Abstract][Full Text] [Related]
17. Age- and stage-dependent glyoxalase I expression and its activity in normal and Alzheimer's disease brains. Kuhla B; Boeck K; Schmidt A; Ogunlade V; Arendt T; Münch G; Lüth HJ Neurobiol Aging; 2007 Jan; 28(1):29-41. PubMed ID: 16427160 [TBL] [Abstract][Full Text] [Related]
18. Truncated tau at D421 is associated with neurodegeneration and tangle formation in the brain of Alzheimer transgenic models. Zhang Q; Zhang X; Sun A Acta Neuropathol; 2009 Jun; 117(6):687-97. PubMed ID: 19190923 [TBL] [Abstract][Full Text] [Related]
19. 14-3-3 protein beta isoform is associated with 3-repeat tau neurofibrillary tangles in Alzheimer's disease. Sugimori K; Kobayashi K; Kitamura T; Sudo S; Koshino Y Psychiatry Clin Neurosci; 2007 Apr; 61(2):159-67. PubMed ID: 17362433 [TBL] [Abstract][Full Text] [Related]